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Abstract
 
Splenectomized individuals are prone to overwhelming infections with encapsulated bacteria
and splenectomy of mice increases susceptibility to streptococcal infections, yet the exact
mechanism by which the spleen protects against such infections is unknown. Using congeni-
tally asplenic mice as a model, we show that the spleen is essential for the generation of B-1a
cells, a B cell population that cooperates with the innate immune system to control early bacte-
rial and viral growth. Splenectomy of wild-type mice further demonstrated that the spleen is
also important for the survival of B-1a cells. Transfer experiments demonstrate that lack of
these cells, as opposed to the absence of the spleen per se, is associated with an inability to
mount a rapid immune response against streptococcal polysaccharides. Thus, absence of the
spleen and the associated increased susceptibility to streptococcal infections is correlated with
lack of B-1a B cells. These findings reveal a hitherto unknown role of the spleen in generating
and maintaining the B-1a B cell pool.
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Introduction
 
Absence of the spleen predisposes individuals to a risk of
overwhelming infection, most often due to the encapsu-
lated bacterium 
 
Streptococcus
 
 
 
pneumoniae
 
 (1). Various hy-
potheses have been proposed to account for this increased
infection risk in asplenic individuals, including lack of op-
sonins or marginal zone (MZ)
 
*
 
 macrophages, altered T cell
function, impaired clearance by the reticuloendothelial sys-
tem, and mechanical filtration of pathogens by the spleen
(2). Congenital asplenia in humans is often associated with
complex heart defects and abdominal heterotaxy resulting
from a laterality defect that begins to develop before spleen
fate is specified (3). While cases of isolated congenital asple-
nia with no other obvious abnormalities have been re-
ported (4, 5), such individuals have seldom been docu-
mented. This may reflect that congenital asplenia is a rare
occurrence but, alternatively, it has been proposed that
such individuals die early in childhood from overwhelming
sepsis, without an autopsy being performed (6–8).
There are, broadly speaking, two major branches of the
immune response to invading microorganisms. The in-
nate immune system provides immediate protection by
promptly initiating a local inflammatory reaction. The
adaptive immune system expands antigen-specific T and B
cells in the lymphoid organs and provides long-lasting pro-
tection against subsequent infections by the generation of
memory T and B cells. In the mouse, a population of B
cells, known as B-1a, cooperates with the innate immune
system at the onset of bacterial and viral infections (9). B-1a
cells produce natural antibodies, mostly IgM, assumedly
without prior exposure to antigen. Such antibodies recog-
nize thymus-independent antigens, such as the polysaccha-
rides of encapsulated bacteria (10). By opsonizing invading
pathogens, they play a crucial role in the activation of the
complement cascade and the amplification of early innate
defense mechanisms (11).
To understand the role of the spleen in the response to
bacterial polysaccharides, we have used the 
 
Hox11
 
-null
mouse as a model of congenital asplenia (12, 13). We show
that the spleen is indispensable for the generation and
maintenance of the B-1a pool. Congenitally asplenic and
splenectomized mice have reduced B-1a cells and a dimin-
ished IgM-mediated immune response against bacterial
polysaccharide antigens.
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Materials and Methods
 
Mice.
 
C57BL/6, 
 
Hox11
 
-null, 
 
Rag-2
 
-null, and SCID mice
were bred and housed in specific pathogen-free conditions in the
institute’s animal facility. All mice used were aged 6–10 wk. The
 
Hox11
 
-null mice were on a mixed genetic background of MF1
(12.5%) and C57BL/6 (87.5%). For splenectomies and sham-oper-
ations, C57BL/6 mice were anaesthetized and after shaving, a
small incision was made in the skin at the left flank. The perito-
neum was opened and the splenic artery and vein ligated with
catgut (Ethicon). The spleen was removed and the incision closed
with surgical silk-thread (Ethicon). For sham-operated mice, the
peritoneum was opened and surgically closed.
 
FACS
 
®
 
 Analysis.
 
Antibodies used for lymphocyte stainings
were anti–mouse CD5-Biotin (clone 53–7.3; BD PharMingen),
anti–mouse B220-PE (clone RA3–6B2; Southern Biotechnology
Associates), anti–mouse IgM-Cy5 (Jackson ImmunoResearch
Laboratories), anti–mouse IgD-FITC (clone 11.26c2a; Southern
Biotechnology Associates), anti–Mac-1 (clone M1/70, own),
anti–mouse CD23-Biotin (clone B3B4; BD PharMingen), and
anti–mouse CD21-FITC (clone 7G6, own). Biotinylated anti-
bodies were detected with Streptavidin-Red670 (GIBCO BRL
and Life Technologies). Mouse peritoneal cells were isolated by
peritoneal lavage with 5 ml FACS
 
®
 
 buffer, containing PBS with
3% FCS (vol/vol) and 0.01% (wt/vol) sodium azide. For the
analysis of splenic lymphocytes, single-cell suspensions of total
splenic tissue were prepared and depleted of erythrocytes by lysis
with Gey’s solution. 2 
 
 
 
 10
 
6
 
 cells per sample were incubated
with varying combinations of antibodies as indicated. Four-color
flow cytometry was performed on a FACSCalibur™ flow cytom-
eter (Becton Dickinson). Each analysis shown represents 200,000
events within the live lymphocyte gate. Flow cytometric profiles
were analyzed using CELLQuest™ software (Becton Dickinson).
 
Immunization.
 
C57BL/6 and 
 
Hox11
 
-null mice were immu-
nized either subcutaneously, intramuscularly, intraperitoneally, or
intravenously with 10 
 
 
 
l Pneumovax
 
®
 
 23 in 100 
 
 
 
l PBS. Pneu-
movax
 
®
 
 23 (Pasteur Merieux MSD GmbH) contains polysaccha-
rides of 
 
Streptococcus pneumoniae
 
 of 23 capsular types each at a con-
centration of 50 
 
 
 
g/ml. Splenectomized and sham-operated mice
were immunized directly after the operation, while still under
narcosis. Mice were bled 24 h before and 6 d after immunization.
The serum was isolated and used for Pneumovax
 
®
 
 23-specific
anti–mouse IgM ELISA. Serum concentrations from 1:20 to 1:640
were tested. The 1:80 dilution is shown, as below this dilution se-
rum IgM levels measured in 
 
Hox11
 
-null and splenectomized
mice were not above background levels.
 
ELISA.
 
ELISA plates (Nunc Maxisorb) were coated with ei-
ther 5 
 
 
 
l Pneumovax
 
®
 
 23, 10 
 
 
 
g/ml phosphorylcholine (Sigma-
Aldrich), or 10 
 
 
 
g/ml pneumococcal polysaccharide type 19
(American Type Culture Collection) in 50 
 
 
 
l PBS for 2 h at
37
 
 
 
C. All incubation steps were performed in a humid chamber.
Blocking was achieved by addition of 200 
 
 
 
l 1% (wt/vol) BSA,
0.1% sodium azide in PBS followed by incubation overnight at
4
 
 
 
C. Plates were then washed three times with 200 
 
 
 
l PBS con-
taining 0.05% (vol/vol) Tween 20 (Sigma-Aldrich) in a Skan-
washer 300 (Skatron Instruments). 50 
 
 
 
l of diluted serum was
added to each well followed by incubation for 2 h at 37
 
 
 
C. Plates
were washed three times with PBS/Tween and 50 
 
 
 
l 1 
 
 
 
g/ml
goat anti–mouse IgM alkaline phosphatase-labeled antibody
(Southern Biotechnology Associates) was added. Plates were in-
cubated for 2 h at 37
 
 
 
C, washed three times with PBS/Tween,
and 100 
 
 
 
l 1 mg/ml SIGMA 104 phosphatase substrate (Sigma-
Aldrich) in DEAE buffer were added. Emitted light was mea-
sured at 405 and 490 nm at various time-points afterwards. Total
serum IgM antibodies were detected similarly except that plates
were first coated with 50 
 
 
 
l 1 
 
 
 
g/ml goat anti–mouse IgM
(Southern Biotechnology Associates) followed by addition of di-
luted serum. For measurements of total IgM sera were diluted be-
tween 1:500 and 1:8,000. The 1:1,000 dilution is shown. Mouse
IgM (Roche Biochemicals) was used as a standard control.
 
Bone Marrow and Fetal Liver Transfer.
 
At least 3 d before irra-
diation, recipient mice were placed on antibiotics (0.12% (wt/
vol) Borgal (Hoechst Russel) in the drinking water). The mice
were maintained on antibiotics until sacrifice. 1 d before transfer,
recipient mice were sublethally irradiated with 300 rads for 
 
Rag2
 
-
null and SCID mice and 600 rads for 
 
Hox11
 
-null mice. 2 
 
 
 
 10
 
6
 
fetal liver cells of day 14.5 embryos or adult bone marrow cells in
200 
 
 
 
l PBS were injected intravenously into the tail vein. For
immunization with Pneumovax
 
®
 
 23, reconstituted mice were
bled 19 d after transfer and injected 24 h thereafter with 10 
 
 
 
l
Pneumovax
 
®
 
 23 in 100 
 
 
 
l PBS, either subcutaneously, intramus-
cularly, intraperitoneally, or intravenously. Serum was taken 6 d
after immunization and used for the detection of Pneumovax
 
®
 
23-specific IgM by ELISA. Mice were then killed and bone mar-
row, spleen, lymph node, and peritoneal cells analyzed by FACS
 
®
 
to confirm complete reconstitution.
 
Statistical Analysis and Graphics.
 
Statistical analysis and graph-
ics were done with Microsoft
 
®
 
 Excel and GraphPad Prism
 
®
 
. Stu-
dent’s 
 
t
 
 tests with 
 
P
 
 values 
 
 
 
0.05 were taken as significant.
 
Results
 
Hox11-Null Mice Lack B-1a Cells.
 
We have previously
shown that the spleen plays a major role in the late phases
of B cell development. Transitional 1 (T1) B cells, recently
emigrated from the bone marrow, accumulate in the spleen
and here differentiate to transitional 2 (T2) and mature B
cells (19). To further study the function of the spleen in the
development of B cells, we analyzed congenitally asplenic
 
Hox11
 
-null mice (12, 13). Of the major B cell and T cell
populations from bone marrow, lymph node, and thymus
analyzed by FACS
 
®
 
, we could not detect any gross pheno-
typic abnormalities. A minor increase in the number of T1
B cells in bone marrow and peripheral blood was observed,
perhaps reflecting a shortage of space, as these cells nor-
mally collect in the spleen. Reductions were also observed
in the proportion of mature B cells in blood, lymph node,
and bone marrow (data not shown). This confirms the role
of the spleen in the generation of normal numbers of ma-
ture B cells. The most striking finding, however, was a
large reduction in the total cell number in the peritoneal
cavity of 
 
Hox11
 
-null mice (8.9 
 
 
 
 2.0 
 
 
 
 10
 
6
 
 in C57BL/6,
5.1 
 
 
 
 1.0 
 
 
 
 10
 
6
 
 in 
 
Hox11
 
-null, Fig. 1 A). However, in the
peritoneal lymphocyte population there was no significant
difference in the proportion of total B cells between
C57BL/6 and 
 
Hox11
 
-null (59.5% 
 
 
 
 5.7% in C57BL/6,
69.1% 
 
 
 
 6.6% in 
 
Hox11
 
-null). Thus, nonB cells including
T cells but also myeloid cells are reduced in the peritoneal
cavity of 
 
Hox11
 
-null mice.
To identify the different populations of B cells in the
peritoneal cavity we used antibodies against IgM, IgD,
B220, and CD5. This antibody combination allows the dis- 
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crimination of all three B cell populations within the peri-
toneal cavity so far described: B-1a, B-1b, and B-2 B cells
(14). Peritoneal B cells of C57BL/6 and 
 
Hox11
 
-null mice
were gated into IgM
 
pos
 
IgD
 
dull
 
 B-1 (Fig. 1 B, gate 1, left
panels) and IgM
 
dull
 
IgD
 
pos
 
 B-2 cells (Fig. 1 B, gate 2, left
panels) and analyzed for expression of B220 and CD5 (Fig.
1 B, right panels). B-1a cells (IgM
 
pos
 
IgD
 
dull
 
CD5
 
pos
 
B220
 
dull
 
)
comprised 23.1% 
 
 
 
 5.0% of all peritoneal B cells in
C57BL/6 mice, whereas these cells were only 3.3% 
 
 
 
1.6% of all peritoneal B cells in 
 
Hox11
 
-null mice (Fig. 1
C). The few CD5
 
pos
 
 B cells in 
 
Hox11
 
-null mice were dif-
ferent from those typically referred to as B-1a cells, in that
they expressed high levels of B220 (Fig. 1 C, indicated by
the arrow). B-1b (IgM
 
pos
 
IgD
 
dull
 
CD5
 
neg
 
B220
 
pos
 
) and mature
B-2 cells (IgM
 
dull
 
IgD
 
pos
 
CD5
 
neg
 
B220
 
pos
 
) were phenotypi-
cally normal in 
 
Hox11
 
-null mice (Fig. 1 B). B-1b com-
prised 13.5% 
 
 
 
 3.6% of all peritoneal B cells in C57BL/6
mice and 18.3% 
 
 
 
 4.8% in 
 
Hox11
 
-null mice. Mature B
cells comprised 24.0% 
 
 
 
 4.8% of all peritoneal B cells in
C57BL/6 mice and 44.6% 
 
 
 
 7.1% in 
 
Hox11
 
-null mice.
Several other markers can be used to discriminate be-
tween B-1 and B-2 cells: B-1 cells are Mac-1
 
pos
 
, CD43
 
pos
 
,
and CD23
 
neg
 
, whereas B-2 cells are CD23
 
pos
 
, Mac-1
 
neg
 
, and
CD43
 
neg
 
 (15–17). Stainings with combinations of these an-
tibodies verified that the B-1a population was reduced in
the peritoneal cavity of 
 
Hox11
 
-null mice (data not shown).
As B-1 cells are known to be the major source of natural
antibodies and most of the circulating IgM is contributed
by B-1a cells in the absence of previous antigen stimulation
(10), serum IgM levels in the blood of mutant and C57BL/6
mice were compared, revealing significantly lower levels in
 
Hox11
 
-null mice (Fig. 1 D). B-1a cells are not only present
Figure 1. The spleen is important for the genera-
tion of peritoneal B-1a cells in the mouse. (A) The to-
tal number of peritoneal cells is shown for 16-wk-old
C57BL/6 (n   10) and Hox11-null (n   10) mice.
Hox11 /  and C57BL/6 mice do not differ in any of
the peritoneal B cell compartments; thus C57BL/6
were used as controls throughout the paper. (B) Peri-
toneal cavity cells of one C57BL/6 and one Hox11-
null mouse were stained with antibodies against IgM,
IgD, CD5, and B220 and analyzed by flow-cytome-
try. The relative expression of IgM and IgD can be used to discriminate IgMposIgDdull B-1 (gate 1) from IgMdullIgDpos B-2 cells (gate 2, left panels). Based
on the expression of IgM and IgD, B-1 and B-2 cells were gated as indicated and analyzed for the expression of B220 and CD5 to further distinguish be-
tween CD5posB220dull B-1a cells (top region, bottom right panels) and the CD5negB220pos B-1b population (bottom region, bottom right panels). While
B-1b cells are normal in Hox11-null mice, the B220dullCD5pos B-1a population is absent. B-2 cells (gate 2) are CD5negB220pos mature B cells (top right
panels). The CD5posB220pos B-1a population that remains in Hox11-null mice is indicated with an arrow. (C) The proportion of B-1a cells in the perito-
neum of C57BL/6 (n   8) and Hox11-null (n   8) are shown. Peritoneal B cells (IgMpos and/or IgDpos) were measured by flow cytometric analysis and
IgMposIgDdullCD5posB220dull were classified as B-1a cells. (D) Relative serum IgM levels in blood of C57BL/6 (n   10) and Hox11-null mice (n   9)
were determined by anti-IgM ELISA. Each data point represents the relative serum IgM level of one mouse measured at a 1:1,000 dilution. 
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within the peritoneal cavity but can also be detected in
spleen and to very low amounts in lymph nodes (18). We
found that B-1a cells are also present in the blood. We
stained peripheral blood with antibodies against IgM, IgD,
CD5, and either B220 or Mac-1. The IgM
 
pos
 
IgD
 
dull
 
 popu-
lation includes T1 B cells, recently emigrated from the
bone marrow, B-1a, and B-1b cells (Fig. 2 A and B). In the
peripheral blood lymphocyte population, the proportion
of total B cells was not significantly different between
C57BL/6 and 
 
Hox11
 
-null mice (Fig. 2 C).
B-1a cells represent a significant proportion of B cells in
the peripheral blood of C57BL/6 mice. B220
 
dull
 
 B-1a cells
were absent from the blood of 
 
Hox11
 
-null mice (Fig. 2 A
and C) but, as in the peritoneal cavity of 
 
Hox11
 
-null mice,
a few CD5
 
pos
 
B220
 
pos
 
 cells could be detected (indicated by
the arrow in Fig. 2 A). To distinguish between T1 and B-1b
cells we analyzed the expression of CD5 and Mac-1 on
 
gated IgM
 
pos
 
IgD
 
dull
 
 cells. Transitional B cells do not express
CD5 and Mac-1. In normal mice, they exit the bone mar-
row and collect in the spleen (19), but in asplenic mice
they accumulate in the blood (Fig. 2 B and C). There was
no change in the B-1b cell population (CD5
 
neg
 
Mac-1
 
pos
 
)
but a slight reduction in the proportion of mature B cells in
asplenic mice (Fig. 2 B and C).
 
Hox11
 
 is expressed in the branchial arches, the develop-
ing hindbrain, the spinal cord, the pharynx, the outflow
tracts of the heart, the external auditory meatus, the neurons
of the developing cranial sensory ganglia, and in the spleen
capsule and trabeculae, but not in hematopoietic cells dur-
ing fetal life (12, 13). Extensive analysis of the spleen, bone
marrow, and peritoneal cavity of adult and neonatal mice
did not reveal any evidence of 
 
Hox11
 
 expression in B cells
(data not shown). To formally exclude the possibility that
the reduction of the B-1a cell pool in 
 
Hox11
 
-null mice was
Figure 2. B-1a cells are absent
in the blood of asplenic mice.
(A) Representative flow cyto-
metric analysis of peripheral
blood cells isolated from
C57BL/6 and Hox11-null mice.
Cells were stained with antibod-
ies against IgM, IgD, CD5, and
B220. IgMdullIgDpos (left panels,
top region) and IgMposIgDdull B
lymphocytes (left panels, bottom
region) were gated and analyzed
for B220 versus CD5 expression
(right panels). IgMdullIgDpos cells
are B220posCD5neg mature B
lymphocytes (top right panels).
Gated IgMposIgDdull B lympho-
cytes (bottom right panels) com-
prise CD5posB220dull B-1a cells
(top region) and CD5negB220pos
B-1b and T1 cells (bottom re-
gion). The CD5posB220pos B-1a
population that remains in
Hox11-null mice is indicated
with an arrow. (B) Representa-
tive flow cytometric analysis of
cells stained with antibodies
against IgM, IgD, CD5, and
Mac-1 isolated from blood of the
same C57BL/6 and Hox11-null
mice analyzed in A. IgMposIgDdull
B-lymphocytes were gated and
analyzed for Mac-1 versus CD5
expression. Gated IgMposIgDdull
B lymphocytes comprise
CD5posMac-1pos B-1a cells (indi-
cated by arrow), CD5negMac-1pos
B-1b, and CD5negMac-1neg T1
cells. (C) Relative proportions of
the major B cell populations in
the peripheral blood of C57BL/6
and  Hox11-null mice. Each
value is the average of measure-
ments obtained in five mice. For
the purpose of measurement,
B-1a cells are defined as
IgMposIgDdullB220dullCD5pos, B-1b as IgMposIgDdullMac-1posCD5neg, and T1 as IgMposIgDdullMac-1negCD5neg. IgMposIgDdull cells constituted 26.5%  
5.7% of total B cells (IgMpos and/or IgDpos) in the blood of C57BL/6 and 39.5%   6.5% in Hox11-null mice.775 Wardemann et al.
due to an intrinsic hematopoietic defect, rather than due to
the absence of the spleen, we transferred Hox11-null fetal
liver cells into SCID mice, which lack both B and T cells.
This protocol allows the reconstitution of all lymphocyte
populations including B-1a and B-1b cells with cells of do-
nor origin (18). 4 wk after transfer, B-1a cells were detect-
able in the peritoneal cavity of SCID mice reconstituted
with Hox11-null fetal liver cells (Fig. 3 A). Thus, Hox11-
null progenitors retain the ability to generate B-1a cells, but
are unable to do so in the absence of the spleen. A control
transfer of C57BL/6 fetal liver cells into irradiated Hox11-
null mice was also performed (Fig. 3 B). The majority of
B-1a cells was still absent although a small number of
B220dull B-1a cells was present. This indicates that there
may be a limited capacity to generate some B-1a cells from
wild-type precursors in the absence of the spleen.
Removal of the Spleen Depletes the B-1a Pool. To investi-
gate whether the spleen plays a role in the maintenance of
an already established B-1a cell pool, we splenectomized
normal C57BL/6 mice and determined the frequency of all
peritoneal B cell populations at various time points thereaf-
ter. Cells were stained with antibodies against IgM, CD5,
B220, and Mac-1 and the proportion of IgMposMac-
1posCD5posB220dull B-1a cells was determined at various
time points thereafter (Fig. 4). There was a similar reduc-
tion in the number of B-1a cells in splenectomized and
sham-operated mice in the first 2 d. However, after day 3,
the proportion of B-1a cells in sham-operated mice began
to recover whereas in splenectomized mice it declined fur-
ther. 6 d after the removal of the spleen, CD5posB220dull
B-1a cells were  1/4 of those in sham-operated mice and
appeared to stabilize at this level as further measurements at
10, 14 and 26 d after splenectomy revealed little change
(Fig. 4 A and B). The frequency of B-1b remained stable
after splenectomy (Fig. 4 C). Therefore, the spleen is indis-
pensable for the maintenance of an already established B-1a
cell pool.
Despite the significant reduction, a fraction of B-1a cells
survived in splenectomized mice. Our observations suggest
that  75% of the peritoneal B-1a cells require the spleen
Figure 3. B-1a cells can be generated from Hox11-null fetal liver. (A)
Fetal liver cells from C57BL/6 or Hox11-null mice were injected intrave-
nously into irradiated SCID mice. 4 wk later peritoneal cavity cells of re-
constituted mice were stained with antibodies against IgM, IgD, CD5,
and B220. Data were analyzed by FACS® and compared with nonrecon-
stituted SCID mice. B lymphocytes of reconstituted mice were gated
based on IgM and/or IgD expression to remove non-B cells. (B) Fetal
liver cells from C57BL/6 mice were injected intravenously into irradiated
Rag2-null or Hox11-null mice. Peritoneal cells were analyzed 4 wk later
as described in A.
Figure 4. The peritoneal B-1a cell pool is rapidly reduced following sple-
nectomy. (A) Representative FACS® analysis of peritoneal B cells isolated
10 d after splenectomy or sham operation and gated for IgMposMac-1pos
cells. A reduction of the CD5posB220dull B-1a population can be seen. (B)
Time course of reduction in B-1a cells upon splenectomy. C57BL/6
mice were either splenectomized or sham-operated and the frequency of
B220dullCD5posIgMposMac-1pos B-1a cells determined by flow-cytometry
at the indicated time points after surgery. At least three splenectomized
and two sham-operated mice were examined for each time point, except for
sham-operated day 6 where the cell number from only one mouse is shown.
(C) Similar time course for B220posCD5negIgMposMac-1pos B-1b cells.776 Dependence of B-1a Cells on the Spleen
for their generation and survival while the rest can survive
without the spleen for at least 26 d. B-1a cells are consid-
ered a self-replenishing population, originally derived from
fetal liver progenitors (18). The depletion of the majority
of B-1a cells after splenectomy suggests that the spleen is
indispensable either for their self-renewal or for their selec-
tion into the B-1a pool. We have previously shown that
the spleen plays a role in the differentiation of transitional
into mature B cells (19). We now demonstrate that the
spleen is also required for a normal B-1a cell pool. In con-
trast, the spleen is not necessary for the development and
survival of B-1b cells.
Asplenic Mice Do Not Respond To Vaccination with Strepto-
coccal Polysaccharides. B-1a cells are responsible for the pro-
duction of IgM against thymus-independent antigens such
as polysaccharides and phospholipids of the bacterial capsule
(20–22) and are known to participate in the early response
to bacterial and viral infection (9, 10, 23). The polysaccha-
ride bacterial capsule is the major virulence factor of S.
pneumoniae. Protective IgM antibodies have the function to
opsonize the bacteria and facilitate their phagocytosis. Us-
ing mice challenged with a noncapsular strain of S. pneumo-
niae, it has been well documented that the major protective
immune response is directed toward phosphorylcholine
(24–26). The response against phosphorylcholine is also T
cell independent. Levels of natural antibody against phos-
phorylcholine and pneumococcal polysaccharide were re-
duced in Hox11-null mice (18.2%   17.4% in Hox11-null
mice, n   16, compared with 100.0%   69.6% in C57BL/6,
n     14, for antiphosphorylcholine; 20.4%   27.2% in
Hox11-null mice compared with 100.0%   108.8% in
C57BL/6 for antipneumococcal polysaccharide). To deter-
mine if the absence of the spleen affected B-1a–dependent
immune responses, Hox11-null, splenectomized, sham-
operated, and control mice were immunized subcutane-
ously, intramuscularly, intraperitoneally, or intravenously
with Pneumovax® 23, a vaccine composed of polysaccha-
rides from the 23 most common types of Streptococcus pneu-
moniae (27). Control and sham-operated mice rapidly pro-
duced Pneumovax®-specific IgM antibodies via all four
injection routes, while Hox11-null (Fig. 5 A) and splenec-
tomized mice (Fig. 5 B) failed to respond.
The Spleen, in the Absence of B-1a Cells, Is Not Sufficient for
a Normal Immune Response to Bacterial Polysaccharides. To
exclude the possibility that the absence of the spleen itself,
rather, or in addition to, the lack of B-1a cells, was respon-
sible for the failure of the immune response, we generated
mice lacking B-1a cells but possessing a spleen. To do this,
Figure 5. Hox11-null and splenectomized
mice do not respond to vaccination with strep-
tococcal polysaccharides. Pneumovax® 23 was
injected subcutaneously, intramuscularly, intra-
peritoneally, or intravenously into either (A)
C57BL/6 and Hox11-null mice or (B) sham-
operated and splenectomized mice. Specific IgM
antibodies in sera were measured by ELISA be-
fore and 6 d after immunization. The optical
density (OD405) measured with a 1:80 serum di-
lution is shown. Each data point indicates the
relative antibody level of a single mouse.777 Wardemann et al.
bone marrow or fetal liver cells were transferred into Rag2-
null mice (Fig. 6). It has been reported that transfer of bone
marrow cells repopulates all major B cell populations with
the exception of B-1a cells, whereas transfer of fetal liver
cells also repopulates the B-1a population (18). 4 wk after
transfer the major B cell populations in bone marrow
(pro-B and pre-B, immature, transitional, and recirculat-
ing), spleen (T1, T2, and mature), and lymph nodes (ma-
ture) were analyzed. All these populations were present
(data not shown). However, as expected, the peritoneal
CD5pos B220dull B-1a population was lacking in the mice
transferred with bone marrow but present in the mice that
had received fetal liver cells (Fig. 6 A). Interestingly
CD5posB220pos B cells (indicated by the arrow in Fig. 6 A)
phenotypically identical to residual CD5pos B cells of
Hox11-null mice (see also Fig. 1 B) were detectable after
bone marrow transfer, suggesting they are not only phe-
notypically but also ontogenetically distinct from the
CD5posB220dull B-1a cells.
To confirm that the B220dull B-1a cells are indeed the
cells responsible for the production of IgM against bacterial
polysaccharides, the reconstituted mice were immunized
subcutaneously, intramuscularly, intraperitoneally, or intra-
venously with Pneumovax® 23 and the production of spe-
cific IgM was measured. Mice transferred with fetal liver
cells, and, thus, possessing B-1a cells, produced specific
IgM, regardless of the route of immunization. In contrast,
mice transferred with bone marrow and, thus, lacking B-1a
cells failed to respond (Fig. 6 C and D). Therefore, the
presence of B-1a cells is required to induce an immune re-
sponse to streptococcal polysaccharides. In contrast, the
presence of the spleen, B-1b, and B-2 cells in the absence
of B-1a cells is not sufficient.
The importance of MZ B cells in response to T cell–
independent antigens has been recognized (28–30). Mice
transferred with bone marrow cells possessed normal num-
bers of CD23negCD21brightIgMbright MZ B cells (reference
19; Fig. 6 B), but their inability to respond to bacterial
polysaccharides indicates that in the absence of B-1a cells,
MZ B cells are not sufficient for a response to Pneumovax®
23. The impaired response to streptococcal polysaccharides
in mice lacking B-1a cells may indicate that B-1a and B-1b
cells are not only ontogenetically (31), but also function-
ally, distinct. Thus, in Hox11-null, splenectomized and
bone marrow reconstituted mice, there is a direct correla-
tion between absence of B-1a cells and lack of immune re-
sponse to streptococcal polysaccharides.
Discussion
Using asplenic Hox11-null mice, we have shown that
the spleen is required for the normal development of the
B-1a population. The origin and differentiation of B-1a
cells is controversial. At one time, B-1a cells were assumed
to be ontogenetically distinct from B-2 cells, based on the
observation that they are derived from fetal liver but not
adult bone marrow (26). The absence of N nucleotide ad-
dition and the preferential usage of proximal V gene seg-
ments in fetal precursors are possible reasons for the gener-
ation of high numbers of B-1 cells from fetal liver but not
from adult bone marrow (32). More recent data show that
B-1a cells may develop from conventional B cell precursors
as a consequence of positive selection after encounter with
antigen (33, 34). It is conceivable that this selection occurs
in the spleen and the presence of B-1a precursor cells in the
spleen has been described previously (35). Therefore, the
spleen may offer a specialized microenvironment where
Figure 6. Mice lacking B-1a cells but
possessing a spleen fail to respond to
immunization with streptococcal
polysaccharides. (A) Fetal liver (FL) or
bone marrow (BM) cells from C57BL/6
mice were injected intraperitoneally
into irradiated Rag2-null mice and four
weeks later reconstituted mice were an-
alyzed. A representative FACS® analysis
of total ungated peritoneal cells stained
for CD5 and B220 from a FL- and a
BM-transferred mouse is shown above.
The CD5posB220dull B-1a cell popula-
tion is boxed. The CD5posB220pos B
cells phenotypically identical to residual
CD5pos B cells of Hox11-null mice are
indicated by a box and arrow. (B) Rep-
resentative FACS® analyses of CD23neg-
gated spleen cells stained for CD21 and
IgM from a FL- and a BM-transferred
mouse are shown. The normal position
of the MZ B cell population (MZ) is
boxed. (C) Specific IgM antibodies in sera of transferred mice. Pneumovax® 23 was injected intraperitoneally 20 d after transfer. Antibodies were mea-
sured by ELISA 1 d before and 6 d after Pneumovax® 23 injection. The optical density (OD405) measured with a 1:80 serum dilution is shown. Each data
point indicates the relative antibody level of a single mouse. (D) The response to Pneumovax® 23 of mice transferred with either bone marrow (BM) or
dE14.5 fetal liver cells (FL) is shown as mean fold-increase of specific serum IgM as detected by ELISA. The optical density (OD405) was measured with
a 1:80 serum dilution. For each route of injection, five mice were transferred with bone marrow and three with fetal liver cells.778 Dependence of B-1a Cells on the Spleen
ligand-dependent positive selection of B-1a precursors oc-
curs. In addition, the spleen may function as a reservoir of
fetal liver–derived B-1a precursors in adult life.
A few CD5pos B-1a cells were still present in the perito-
neal cavity and the blood of Hox11-null mice and could
also be detected in the peritoneal cavity of irradiated Rag2-
null mice 4 wk after transfer of C57BL/6 bone marrow.
However, these cells express higher levels of B220 and
slightly lower levels of CD5 as compared with the
CD5posB220dull B-1a cells of C57BL/6 animals. This sug-
gests that CD5pos B cells might consist of two distinct sub-
populations. B220dull CD5 cells, corresponding to B-1a B
cells, are strictly dependent on the spleen for their genera-
tion, and develop rapidly in high numbers from fetal liver
precursors. In contrast, B220pos CD5 cells can be generated
in the absence of the spleen, can be derived from both fetal
liver and adult bone marrow, and in these respects are very
similar to B-1b cells. Our results demonstrate that the
former population is required for natural IgM production
and the response to streptococcal polysaccharide antigens.
Splenectomy of C57BL/6 mice leads to a rapid loss of
 75% of the peritoneal B-1a cell pool. It is unknown
whether the reduction in B-1a cells in splenectomized
mice reflects a defect in their generation, their survival, or a
combination of both. B-1a cell precursors may home to the
spleen from the liver during the fetal life and B-1a B cells
may be continuously generated from these precursors in
the adult. Alternatively, B-1a cells may be long-lived and
their rapid loss upon splenectomy would suggest that they
are unable to survive in the absence of the spleen. This
could reflect the requirement of a factor generated in the
spleen that is essential to B-1a survival. It is possible that
B-1a cells continually circulate through the spleen, where
the interaction with a specialized microenvironment sup-
ports their survival.
B-1a cells were originally identified based on the expres-
sion of CD5 (36), a glycoprotein expressed by all T cells af-
ter positive selection (37, 38). In the B cell compartment,
only B-1a cells are CD5pos. However, CD5 can be induced
on conventional B cells after B cell antigen receptor
(BCR) cross-linking (39) and low levels of CD5 are ex-
pressed by chronically stimulated, anergic B cells (40).
Therefore, it has been proposed that expression of CD5 is
indicative of a prior interaction of B-1a cells with antigen.
The BCRs of B-1a cells comprise not only polyreactive
but also autoreactive specificities and it has been demon-
strated that autoantigens can be responsible for their posi-
tive selection (33). Given that CD5 is a negative regulator
of BCR signaling in B-1a cells (41) and that tight regula-
tion of the activation of B-1a cells specific for autoantigens
is essential, low expression of B220 in addition to up-regu-
lated CD5 expression might downmodulate BCR signals
after positive selection by antigen and thus prevent autoim-
munity (42, 43).
It has been demonstrated that fetal liver– and bone mar-
row–derived B cells have different signaling properties (34).
The CD5posB220pos B cells present in Hox11-null, Rag2-
null reconstituted, and C57BL/6 mice may be B-1a pre-
cursors that do not, for some reason, downmodulate B220
after interaction with ligand in the spleen. The reduced
threshold for signaling in such cells may contribute to au-
toimmune phenomena attributed to CD5pos B cells. Alter-
natively, these cells may be ontologically distinct from typ-
ical B-1a cells. Their presence after C57BL/6 bone marrow
transfer into Rag2-null mice indicates that they are a bone
marrow–derived population.
At the outset, bacterial infections are often localized and
are initially exposed to components of the innate immune
system. Natural IgM antibodies secreted by B-1 cells are
part of this system and play a crucial role in the activation
of the complement cascade and the amplification of early
innate defense mechanisms (11). Hox11-null mice exhibit
significantly reduced levels of serum IgM and of natural
antibodies. In addition, lack of B-1a cells in Hox11-null
and splenectomized mice correlates with an inability to
produce specific IgM in response to T cell–independent
streptococcal polysaccharides. We observed that Pneu-
movax®-specific IgM was produced regardless of the route
of inoculation. Although B-1a cells were originally de-
scribed in the peritoneal cavity, we found B-1a cells in the
peripheral blood. They have also been detected in the
spleen and 50% of the IgA-secreting plasma cells in
the mucosa of the bowel are B-1 derived (44, 45). Fur-
thermore, B-1a cells can be detected in lungs of mice in-
fected with influenza virus (46), suggesting that they may
be able to migrate to sites of infection. Circulation through
the body via the blood could be a mechanism by which
B-1a cells rapidly reach infected and inflamed tissues.
Therefore, this might be important to limit dissemination
of invading pathogens. Thus, the presence of B-1a cells in
the blood might explain the production of Pneumovax®-
specific IgM in C57BL/6 mice regardless of the route of
immunization while Hox11-null mice, lacking peritoneal
and blood B-1a cells, did not respond.
MZ B cells of the spleen contribute to the early immune
response to thymus-independent (TI)-2 antigens (28–30).
However, though MZ B lymphocytes were reconstituted
to normal amounts after transfer of bone marrow cells into
Rag2-null mice, these animals did not produce specific IgM
in response to immunization with streptococcal polysac-
charides. Presence of the spleen including MZ B cells is,
therefore, not sufficient for an adequate response to TI-2
antigens if B-1a cells are absent. It has recently been dem-
onstrated that B-1 cells dominate the response to TI anti-
gens in the peritoneum, while MZ B cells contribute to the
early response to blood-borne particulate TI antigens (47).
Nevertheless, mice possessing B-1a cells but lacking MZ B
cells show an impaired response to the TI-2 antigen TNP-
Ficoll after intraperitoneal administration (28). Hence, it is
possible that both B-1a and MZ cells are required for the
production of specific IgM in response to different repeti-
tive polysaccharide antigens. While MZ B cells may be im-
portant in the late phases of infections when pathogens can
be found in the blood and are filtered into the MZ of the
spleen, B-1a B cells may play a role in the limitation of
early bacterial growth at the site of infection (47).779 Wardemann et al.
In summary, we have demonstrated that the spleen is in-
dispensable for the generation and survival of B-1a cells in
the mouse. This reveals an essential role of the spleen in
producing these cells, and their absence may account for the
concomitant infections that occur in asplenic individuals.
Future experiments will focus on determining how the
spleen functions in the generation and survival of these cells.
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